VKH
ALT icon

Virtu KCG Holdings’s Altimmune ALT Stock Holding History

Virtu KCG Holdings’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-595
Closed -$145K – 2840
2017
Q1 		$145K Buy
595
+502
+540% +$269K ﹤0.01% 2563
2016
Q4 		$90K Sell
93
-63
-40% -$56.4K ﹤0.01% 2951
2016
Q3 		$136K Buy
156
+81
+108% +$63.5K ﹤0.01% 2535
2016
Q2 		$55K Sell
75
-28
-27% -$19.2K ﹤0.01% 2659
2016
Q1 		$58K Buy
103
+61
+145% +$31.2K ﹤0.01% 2431
2015
Q4 		$24K Buy
+42
New +$20.9K ﹤0.01% 3288
2015
Q2 		– Sell
-35
Closed -$17K – 3290
2015
Q1 		$17K Buy
35
+1
+3% +$498 ﹤0.01% 2976
2014
Q4 		$18K Sell
34
-366
-92% -$188K ﹤0.01% 3610
2014
Q3 		$214K Buy
+400
New +$209K ﹤0.01% 2822
2013
Q4 		– Sell
-81
Closed -$51K – 3762
2013
Q3 		$51K Buy
+81
New +$46.4K ﹤0.01% 3504

Other funds holding ALT

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FQ
First Quadrant Glendale, California $18M AUM 24.2% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Virtu KCG Holdings's ALT Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Altimmune (ALT) in Q2 2017, closing a stake of 595 shares — an estimated $145K sold.

Virtu KCG Holdings first reported a position in ALT in Q3 2013 and held it in 10 quarters. The position peaked at $214K in Q3 2014. 42 funds tracked by Wall St. Rank hold ALT as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Altimmune position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 595 Altimmune shares in Q2 2017, an estimated $145K.
  • Virtu KCG Holdings first reported a position in Altimmune in Q3 2013 and held it in 10 quarters.
  • Virtu KCG Holdings's Altimmune position peaked at $214K in Q3 2014.
  • 42 funds tracked by Wall St. Rank held Altimmune as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.